Source: Eur Respir J 2006; 27: 657
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Garcia-Hernandez F. J., Ocana-Medina C., Gonzalez-Leon R., Garrido-Rasco R., Sanchez-Roman J.. Autoimmune polyglandular syndrome and pulmonary arterial hypertension. Eur Respir J 2006; 27: 657

Member's Comments

No comment yet.

Related content which might interest you: The metabolic syndrome and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Pulmonary arterial hypertension: an autoimmune disease? Source: Eur Respir J 2005; 26: 986-988 Year: 2005 Pulmonary hypertension in hypoventilation syndromes Source: Eur Respir J 2014; 43: 12-15 Year: 2004 Pulmonary arterial hypertension associated with congenital heart disease Source: Eur Respir Rev 2012 21: 328-337 Year: 2012 Prevalence of hyperventilation syndrome in pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis Source: Eur Respir Rev 2009; 18: 125-128 Year: 2009 Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy? Source: Eur Respir J 2010; 35: 223-224 Year: 2010 Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 Year: 2020 Pulmonary hypertension in patients with chronic myeloproliferative disorders Source: Eur Respir J 2010; 35: 1396-1406 Year: 2010 Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension Source: Eur Respir Rev 2009; 18: 177-180 Year: 2009 An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview Source: Eur Respir Rev 2012 21:223-233 Year: 2012 Hepatopulmonary syndrome following portopulmonary hypertension Source: Eur Respir J 2007; 29: 1277-1280 Year: 2007 Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012 Portopulmonary hypertension: a further clue to pathogenesis? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 Pulmonary hypertension in systemic scleroderma Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Pulmonary arterial hypertension masquerading as severe refractory asthma Source: Eur Respir J 2008; 32: 513-516 Year: 2008 Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome Source: Eur Respir J 2003 Oct 01;22(4):709-711 Year: 2003